Silhouette

Osmond J D'Cruz

Paradigm Pharmaceuticals, LLC

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Vanadocenes as a New Class of Spermicidal Drugs
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 2 $288K 04/01/07 03/31/08
Vanadocenes as a New Class of Spermicidal Drugs
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 2 $294K 04/15/06 03/31/07
Stampidine: A Novel Broad-Spectrum Anti-HIV Microbicide
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 09/01/05 08/31/06
Phase II SBIR: WHI-07: A Novel Dual-Function Microbicide
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 2 $379K 09/01/05 08/31/07
Phase II SBIR: WHI-07: A Novel Dual-Function Microbicide
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 2 $371K 09/27/04 08/31/05
PHI-443: Novel Non-Spermicidal Anti-HIV Microbicide
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 08/28/03 08/31/04
METVAN: A Novel Anticancer Agent
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 07/01/03 06/30/04
FLP-102: Rationally Engineered Antiviral Protein
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 05/01/03 10/31/04
Vanadocenes as a New Class of Spermicidal Drugs
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 03/25/03 03/31/04
WHI-07: A Novel Dual-Function Microbicide
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 08/01/02 01/31/03
PHI 346: A Novel Dual-Function Microbicide
Paradigm Pharmaceuticals, LLC
Principal Investigator
HHS 1 $100K 01/01/02 12/31/03